According to Benzinga Pro, Quest Diagnostics's peer group average for short interest as a percentage of float is 9.65%, which means the company has less short interest than most of its peers. Did you ...

The analysis of recent analyst actions sheds light on the perception of Quest Diagnostics by financial ... Typically, analysts assess and rate each stock once per quarter. Some analysts will ...

We selected AI stocks by reviewing news articles, stock analysis, and press releases ... providing a risk assessment for a patient. Quest Diagnostics Inc. (NYSE:DGX) leverages technology and ...

Our technical summary section provides analysis on Quest Diagnostics share price buy/sell indicators using real-time data (or discuss the Quest Diagnostics (DGX) stock price today with other investors ...

Penumbra Inc (NYSE: PEN ): Adam Elsesser, CEO and President, sold shares totaling approximately $4.5 million at prices ranging from $267.36 to $277.63 per share. Elsesser also exercised stock options ...

The stock is down 12.4% since reporting and currently trades at $232.71. Is now the time to buy Labcorp? Access our full analysis of the earnings results ... adult U.S. population's lab tests annually ...

Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.

This was the stock's second consecutive day of losses.